American Brachytherapy Society consensus guidelines for high-dose-rate prostate brachytherapy

The clinical outcomes for HDR are excellent, with high rates of biochemical control, even for high-risk disease, with low morbidity. HDR monotherapy, both for primary treatment and salvage, are promising treatment modalities.